Next |
home / stock / evax / evax message board
Subject | By | Source | When |
---|---|---|---|
Back inside the bollinger. Watching to reload. | BooDog | investorshub | 04/18/2023 2:23:15 PM |
$EVAX 1.49. 50 DMA support @ 1.33. | BooDog | investorshub | 04/17/2023 2:03:07 PM |
Took a few more here. Like how | BooDog | investorshub | 04/13/2023 4:42:51 PM |
$EVAX......................................https://stockcharts.com/h-sc/ui?s=$EVAX | glenn1919 | investorshub | 02/08/2023 1:43:58 PM |
1.64 Some may think this is a discount. | BooDog | investorshub | 01/04/2023 1:31:56 PM |
Closed $2.95 up 21.4% regular hours! | subslover | investorshub | 09/23/2022 8:05:18 PM |
maybe your typo will print soon | TheFinalCD | investorshub | 09/23/2022 5:09:37 PM |
HOD $3.07 | subslover | investorshub | 09/23/2022 4:11:46 PM |
2,53 | TheFinalCD | investorshub | 09/23/2022 2:37:41 AM |
Closed $3.50 HOD regular hours. | subslover | investorshub | 09/22/2022 8:02:03 PM |
2.05 pre-market | TheFinalCD | investorshub | 09/22/2022 3:12:01 PM |
Let's see what happens tomorrow. You and I | subslover | investorshub | 09/22/2022 12:23:50 AM |
znewcar1: EVAX 22% v46,M c2.33 f23,8M H3.5199 ML1.9 GapNcrap | znewcar1 | investorshangout | 09/21/2022 9:55:36 PM |
gAp & tRap | TheFinalCD | investorshub | 09/21/2022 8:16:14 PM |
I likes the sound of that | INFINITI | investorshub | 09/21/2022 1:15:59 PM |
Yea and with this kind of news it | subslover | investorshub | 09/21/2022 1:15:35 PM |
Nice News!!! | INFINITI | investorshub | 09/21/2022 1:08:54 PM |
Looks good Im in | INFINITI | investorshub | 09/21/2022 12:57:11 PM |
GARGANTUAN NEWS | subslover | investorshub | 09/21/2022 12:39:07 PM |
Evaxion Biotech Announces Successful Production of Personalized Cancer | subslover | investorshub | 05/10/2022 12:19:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Evaxion Biotech A/S Company Name:
EVAX Stock Symbol:
NASDAQ Market:
Significant Phase 2 clinical trial progress obtained with first patient finalizing EVX-01 vaccine dosing Favorable safety profile confirmed Trial on track for one-year clinical efficacy readout in Q3 2024 COPENHAGEN, Denmark, April 17, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S ...
Evaxion and its collaborator tested Evaxion-designed vaccine antigens against Staphylococcus aureus in a clinically relevant animal model of surgical site infections The vaccine antigens significantly protected large, non-rodent animals against surgical site infections, indicating promisi...
Precision vaccine project initiated with the ambition to obtain Preclinical Proof-of-Concept by H2 2024. The novel concept entails AI-identification of a new class of cancer vaccine targets, named endogenous retroviruses (ERVs), broadening the potential of cancer vaccines. Successful completi...